Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19651172 | 1.00 | LMNA (0.43) | LMNASMPD1GPR84FDPSSPHK1 | |
| SCHEMBL1271235 | 0.86 | CTSK (0.36) | FDPSDNM1 | |
| SCHEMBL27476110 | 0.73 | LMNA (0.48) | LMNASMPD1GPR84FDPSSPHK1 | |
| SCHEMBL31436265 | 0.73 | LMNA (0.48) | LMNASMPD1GPR84FDPSSPHK1 | |
| SCHEMBL27856287 | 0.73 | LMNA (0.43) | LMNASMPD1GPR84FDPSSPHK1 | |
| SCHEMBL23839868 | 0.72 | LMNA (0.34) | LMNASMPD1GPR84FDPSZDHHC7 | |
| SCHEMBL211947 | 0.72 | TSHR (0.47) | LMNASMPD1GPR84FDPSSPHK1 | |
| SCHEMBL1932239 | 0.72 | TSHR (0.47) | LMNASMPD1GPR84FDPSSPHK1 | |
| SCHEMBL4556813 | 0.72 | TSHR (0.47) | LMNASMPD1GPR84FDPSSPHK1 | |
| SCHEMBL1317403 | 0.72 | TSHR (0.47) | LMNASMPD1GPR84FDPSSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975236-B2 | Resin mixture and multilayer structure | KURARAY CO., LTD. (JP) | 2021-04-13 | — | — | US | disclosed |
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | OSAKA UNIVERSITY (JP) | 2020-10-06 | — | — | US | disclosed |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | OSAKA UNIVERSITY (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3564245-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | Osaka University (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-2554373-B1 | MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2016-05-11 | — | — | EP | disclosed |
| EP-2636701-B1 | RESIN MIXTURE AND MULTILAYER STRUCTURE | KURARAY CO (JP) | 2016-02-24 | — | — | EP | disclosed |
| US-8784960-B2 | Multilayer structure and method for producing same | KURARAY CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| EP-2636701-A1 | MIXED RESIN AND MULTILAYER STRUCTURE | Kuraray Co., Ltd. (JP) | 2013-09-11 | — | — | EP | disclosed |
| US-20130225756-A1 | RESIN MIXTURE AND MULTILAYER STRUCTURE | KURARAY CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
| EP-2554373-A1 | MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME | Kuraray Co., Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| EP-1314761-A1 | RESIN COMPOSITION AND MULTILAYERED CONTAINER | KURARAY CO., LTD. (JP) | 2003-05-28 | — | — | EP | disclosed |
| US-20030022974-A1 | Polyvinyl alcohol resin composition and multilayer packages | KURARAY CO., LTD. (JP) | 2003-01-30 | — | — | US | disclosed |
| US-20030018114-A1 | Resin composition and a multilayered container | KURARAY CO., LTD. (JP) | 2003-01-23 | — | — | US | disclosed |
| US-6398059-B1 | Fuel container | KURARAY CO., LTD. (JP) | 2002-06-04 | — | — | US | disclosed |
| EP-1108653-A1 | FUEL CONTAINER | KURARAY CO., LTD. (JP) | 2001-06-20 | — | — | EP | disclosed |
| EP-0616010-B1 | Resin composition | KURARAY CO (JP) | 1998-11-04 | — | — | EP | disclosed |
| US-5741870-A | HAVING AT LEAST ONE BORONIC ACID ESTER GROUP BONDED TO AN SP3 CARBON ATOM OF THE POLYOLEFIN | KURARAY CO., LTD. (JP) | 1998-04-21 | — | — | US | disclosed |
| US-5571871-A | Resin composition | KURARAY CO., LTD. (JP) | 1996-11-05 | — | — | US | disclosed |
| US-5466748-A | Resin composition | KURARAY CO., LTD. (JP) | 1995-11-14 | — | — | US | disclosed |
| EP-0616010-A2 | Resin composition | KURARAY CO., LTD. (JP) | 1994-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | CYP24A1, CYP26B1, CYP21A2 | LMNA 2600/4885SMPD1 1415/4885GPR84 4615/4885 |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | CYP24A1, CYP26B1, CYP21A2 | LMNA 2600/4885SMPD1 1415/4885GPR84 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.